Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-14

Clinical Trial Update: Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a vaccine therapy for newly diagnosed glioblastoma multiforme has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GBM vaccine therapy

Snippet

Sponsor: University of Florida | Conditions: Glioblastoma Multiforme, Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2025-01-14